A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers

10.1128/AAC.03478-14

Saved in:
Bibliographic Details
Main Authors: Leong, F.J, Zhao, R, Zeng, S, Magnusson, B, Diagana, T.T, Pertel, P
Other Authors: MICROBIOLOGY AND IMMUNOLOGY
Format: Article
Published: American Society for Microbiology 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/180135
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1128/AAC.03478-14